Drugdiscovery.pharmaceutical-business-review.com

ANNOUNCEMENTS Director's Corner Podcast: Drug Compounding The Director’s Corner is an audio podcast series featuring the director of FDA’s Center for Drug Evaluation and Research, Dr. Janet Woodcock.  In this podcast, she discusses drug compounding...

In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient...

KEMWELL BIOPHARMA (WWW.KEMWELLBIOPHARMA.COM) Both small and large biopharmaceutical companies are increasingly pursuing the outsourcing of manufacturing and testing throughout the product lifecycle. The growing use of contract manufacturing organizations...

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) is not planning to hold an Advisory Committee meeting for Portola Pharmaceuticals' New Drug Application (NDA) for betrixaban.

Agents of the Food and Drug Administration know better than anyone else just how bad scientific misbehavior can get. Reading the FDA’s inspection files feels almost like watching a highlights reel from a Scientists Gone Wild video. It’s a seemingly endless...